- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01758419
The Role of Myocardial SPECT in Evaluation of Irradiation-induced Changes.
The Role of Myocardial SPECT in Evaluation of Irradiation-induced Changes With Myocardial Perfusion, Cardiac Function, Metabolism and Clinical Prognosis.
Helical tomotherapy nowadays provides the most precise data on radiotherapy (RT) dose delivered to each region of the heart in left-sided breast cancer therapy, which allows greater sparing of the heart from doses associated with increased complications. However, heart disease shows a wide spectrum of pathologies, and multiple risk factors related. The damage of the myocytes may lead to not only myocardial perfusion defects, but also in functional deterioration, or even in biomarkers. In this study, we will monitor cardiovascular (CV) risk factors, metabolism, biomarkers, myocardial perfusion defect patterns, and cardiac functional parameters, in order to delineate of RT-related effects and clinical impacts.
Objective: The pilot study aims to investigate the correlation of post-tomotherapy cardiovascular effects with myocardial perfusion and cardiac functional studies.
Methods: The study plans to enroll female breast cancer patients who will undergo local RT after their surgery. Patients will receive global risk scoring assessment (Framingham Risk Score, FRS), blood sampling for basic biochemistry, inflammatory biomarker, and myocardial perfusion image (MPI) at the time points of before and after RT. The results of MPI will be analyzed in qualitative visual interpretation of perfusion patterns, and functional quantitative data for cardiac functional parameters as well. The patients will be regular followed-up in CV OPD. The association between baseline and follow-up MPI, biomarker and clinical presentation will be further investigated.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Inclusion Criteria:
- Female patients with breast cancer who scheduled further regional RT. Groups of left-sided breast cancer (tomotherapy, conventional RT), and right breast cancer (conventional RT).
- Aged 20-80 years old.
Exclusion Criteria
- Pre-existing cardiac disease, such as prior myocardial infarction, documented CAD, congestive heart failure.
- Pregnancy
- Any medical contraindication of cardiac SPECT.
Estimated Case Number 20 female patients of each groups, respectively Group 1: Left-sided breast cancer, planning to received helical tomography Group 2: Left-sided breast cancer, planning to received local conventional RT Group 3: Right-sided breast cancer, planning to received local RT
- Patients with breast cancer s/p operation will be transferred to CV OPD for initial cardiovascular risk factors assessment.
- Past history, family history, basic lab data and Framingham cardiovascular risk assessment will be applied. Intermediated to high risk need further work-up, and undergo SPECT before further RT course.
- All enrolled subjects provide basic demographic data and sign informed consents.
- Myocardial perfusion images for baseline evaluation before RT.
- The patients received scheduled treatment plan, including RT.
- Follow-up CV OPD every 3 months.
- Post-therapeutic myocardial perfusion study 12 months after first CV OPD visit.
- Comparing the clinical follow-up data between groups, including global functional assessments, blood sampling data, myocardial perfusion scan, and quantitative cardiac functional parameters.
Blood sampling
Myocardial perfusion study- Patients referred for SPECT MPI for evaluation of CAD underwent a 1-day Tl-201 stress/rest MPI protocol, as daily practice in FEMH. Pharmacological stress was induced by standard dipyridomale infusion. Tl-201 of 2 mCi was injected after 7 min of induced stress. Each scan will be performed on an ultrafast CZT camera (Discovery 530 NMc, GE Healthcare). CZT images were reconstructed on the workstation using a dedicated iterative algorithm with maximum likelihood expectation maximization. Perfusion images in standard axis (short axis, vertical long axis, horizontal long axis) and polar maps of the left ventricle were obtained. Scans from CZT was analyzed in consensus by two experienced readers blinded to any information on patient identification.
The software package with a 17-segment model for the left ventricle. Automated analysis of gated acquisitions from high-dose (rest) scans was performed to determine left ventricular ejection fraction. Integrated clinical information, follow-up and nuclear medicine cardiac scans performed in the time points of before & after RT will be collected and analyzed.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
New Taipei City, Taiwan, 220
- Recruiting
- Far Eastern Memorial Hospital
-
Contact:
- Phone Number: +886-277282152
- Email: irb@mail.femh.otg.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Female patients with breast cancer who scheduled further regional RT. Groups of left-sided breast cancer (tomotherapy, conventional RT), and right breast cancer (conventional RT).
- Aged 20-80 years old.
Exclusion Criteria:
- Pre-existing cardiac disease, such as prior myocardial infarction, documented CAD, congestive heart failure.
- Pregnancy
- Any medical contraindication of cardiac SPECT.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Tomotherapy
Breast cancer female s/p scheduled RT will be arranged to undergo Thallium-201 Myocardial Perfusion Study.
The scheduled RT will be arranged by clinical judgments of radiation-oncologists.
All of the patients will receive myocardial SPECT before and after the scheduled RT.
Comparing the clinical follow-up data between different groups (left-sided s/p tomography, left-sided s/p conventional RT, and right-sided RT), respectively.
|
One-day Tl-201 stress/rest MPI protocol with pharmacological stress, as daily practice will be applied.
CZT camera with multipinhole collimator and stationary detectors scan heart simultaneously.
A 10% symmetrical energy window at 140 keV was used.
Electrocardiogram-gated scans will be applied.
Perfusion images were reconstructed in standard axis and polar maps of the left ventricle were obtained.
Scans from CZT was analyzed in consensus by two experienced readers blinded to any information on patient identification.
The software package Myovation for Alcyone, QGS and QPS were used for quantitative analysis of MPI polar maps.
Automated analysis to determine ejection fraction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To investigate the correlation of post-RT cardiovascular effects with myocardial Tl-201 myocardial perfusion images
Time Frame: Dec, 2013 (after 12 months of baseline study).
|
By literature reviewing, cardiovascular functional status in patients received helical tomography has not been fully investigated yet.
And the post-therapeutic heart disease tends to show a wide spectrum of pathologies and multiple risk factors.
We will monitor risk factors of underlying disease, family history, metabolism, biomarkers, myocardial perfusion defect patterns, and cardiac functional parameters, in order to delineation of RT-related effects and clinical prognosis.
|
Dec, 2013 (after 12 months of baseline study).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FEMH-IRB-101085-F
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer, Female
-
University of Kansas Medical CenterRecruitingBreast Cancer FemaleUnited States
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerGermany
-
Oncoliq US IncRecruitingBreast Cancer Female | Breast Cancer Detection | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer With Low to Intermediate HER2 Expression | Breast Cancer - Female | Breast Cancer (Early Breast Cancer) | Breast Cancer - Ductal Carcinoma in Situ (DCIS) | Breast Cancer - Infiltrating...Argentina
-
Dalarna County Council, SwedenRecruitingBreast Cancer - FemaleSweden
-
Al-Quds UniversityNot yet recruitingThe Effect of Psychosocial Support on Improving Breast Cancer Patients Response to Medical TreatmentBreast Cancer - FemalePalestinian Territories
-
Izmir Biomedicine and Genome CenterDokuz Eylul University; Antalya Training and Research Hospital; Akdeniz University...Enrolling by invitationFemale Breast Cancer PatientsTurkey (Türkiye)
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Ahon Pharmaceutical Co., Ltd.RecruitingAdvanced Breast Cancer | Female Breast CancerChina
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany
Clinical Trials on Thallium-201 Myocardial Perfusion Study
-
Far Eastern Memorial HospitalUnknownThoracic Neoplasms | Late Effect of RadiationTaiwan
-
Far Eastern Memorial HospitalCompleted
-
St. Louis UniversityAstellas Pharma US, Inc.WithdrawnCoronary Artery DiseaseUnited States
-
China National Center for Cardiovascular DiseasesNot yet recruiting
-
National Heart Centre SingaporeNational Medical Research Council (NMRC), SingaporeRecruitingCoronary Artery Disease | Diabetes MellitusSingapore
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Walter Reed Army Medical CenterUnknownCoronary Artery Disease | Chest Pain | Coronary Atherosclerosis | Stress TestingUnited States
-
Aspire FoundationBlue Cross Blue Shield; Saint Luke's Cardiovascular Consultants; Cardiovascular... and other collaboratorsCompletedCoronary Artery DiseaseUnited States
-
Montefiore Medical CenterAlbert Einstein College of Medicine; American Heart AssociationCompletedCoronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Unstable AnginaUnited States
-
Ionetix CorporationCompletedMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesUnited States